Glutamine, alanine or glycine repeats inserted into the loop of a protein have minimal effects on stability and folding rates

Journal of Molecular Biology

Volumn 273, Issue 1, 1997, Pages 330-337

  Ladurner, Andreas G ^a   Fersht, Alan R ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Chymotrypsin inhibitor 2; Protein engineering; Protein folding; Transcription

Indexed keywords

ALANINE; CHYMOTRYPSIN INHIBITOR; CHYMOTRYPSIN INHIBITOR 2; GLUTAMINE; GLYCINE; MUTANT PROTEIN; POLYPEPTIDE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CATALYSIS; CONTROLLED STUDY; DNA TRANSCRIPTION; ENZYME ACTIVE SITE; GENETIC ENGINEERING; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN STRUCTURE;

EID: 0031576337     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1997.1304     Document Type: Article

References (47)

1. Bennett M. J., Choe S., Eisenberg D. Domain swapping: entangling alliances between proteins. Proc. Natl Acad. Sci. USA. 91:1994;3127-3131.
2. Bennett M. J., Schlunegger M. P., Eisenberg D. 3D domain swapping: a mechanism for oligomer assembly. Protein Sci. 4:1995;2455-2468.
3. Berleth T., Burri M., Thoma G., Bopp D., Richstein S., Frigerio G., Noll M., Nüsslein-Vollhard C. The role of localization of bicoid RNA in organizing the anterior pattern of theDrosophilia. EMBO J. 7:1988;1749-1756.
4. Chakrabartty A., Schellman J. A., Baldwin R. L. Large differences in the helix propensities of alanine and glycine. Nature. 351:1991;586-588.
5. Chan H. S., Dill K. A. Intrachain loops in polymers. J. Chem. Phys. 90:1988;492-509.
6. Clore G. M., Gronenborn A. M., Kjær M., Poulsen F. M. The determination of the three-dimensional structure of barley serine proteinase inhibitor 2 by nuclear magnetic resonance, distance geometry and restrained molecular dynamics. Protein Eng. 1:1987;305-311.
7. Creighton T. E. Proteins. Structures and Molecular Properties. 1993;W. H. Freeman and Company, New York.
8. Daggett V., Li A. J., Itzhaki L. S., Otzen D. E., Fersht A. R. Structure of the transition state for folding of a protein derived from experiment and simulation. J. Mol. Biol. 257:1996;430-440.
9. Dunitz J. D. Win some, lose some: enthalpy-entropy compensation in weak intermolecular interactions. Chem. Biol. 2:1995;709-712.
10. Fersht A. R. Characterizing transition-states in protein-folding: an essential step in the puzzle. Curr. Opin. Struct. Biol. 5:1995;79-84.
11. Flory P. J. Theory of elastic mechanisms in fibrous proteins. J. Am. Chem. Soc. 78:1956;5222-5235.
12. Frigerio G., Burri M., Bopp D., Baumgartner S., Noll M. Structure of the segmentation gene paired and theDrosophilia. Cell. 47:1986;735-746.
13. Fu X. D. Specific commitment of different pre-mRNAs to splicing by single SR proteins. Nature. 365:1993;82-85.
14. Gerber H. P., Seipel K., Georgiev O., Hofferer M., Hug M., Rusconi S., Schaffner W. Transciptional activation modulated by homopolymeric glutamine and proline stretches. Science. 263:1994;808-811.
15. Hibi T., Nishioka R., Kato H., Tanizawa K., Fukui T., Katsube Y., Oda J. Structure of the multifunctional loops in the non-classical ATP-binding of glutathione synthetase. Nature Struct. Biol. 3:1996;16-18.
16. Hoey T., Weinzierl R. O. J., Gill G., Chen J. L., Dynlacht B. D., Tjian R. Molecular cloning and function alanalysis ofDrosophilia. Cell. 72:1993;247-260.
17. Itzhaki L. S., Otzen D. E., Fersht A. R. The structure of the transition state for folding of chymotrypsin inhibitor 2 analyzed by protein engineering methods: evidence for a nucleation-condensation mechanism for protein folding. J. Mol. Biol. 254:1995;260-288.
18. Jackson S. E., Fersht A. R. Folding of chymotrypsin inhibitor-2. 1. Evidence for a two-state transition. Biochemistry. 30:1991a;10428-10435.
19. Jackson S. E., Fersht A. R. Folding of chymotrypsin inhibitor-2. 2. Influence of proline isomerization on the folding kinetics and thermodynamic characterization of the transition state of folding. Biochemistry. 30:1991b;10436-10443.
20. Jackson S. E., elMasry N., Fersht A. R. Structure of the hydrophobic core in the transition state for folding of chymotrypsin inhibitor-2-a critical test of the protein engineering method of analysis. Biochemistry. 32:1993;11270-11278.
21. Johnson C. M., Oliveberg M., Clarke J., Fersht A. R. Thermodynamics of denaturation of mutants of barnase with disulfide crosslinks. J. Mol. Biol. 268:1997;198-208.
22. Kadonaga J. T., Carner K. R., Masiarz F. R., Tjian R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell. 51:1987;1079-1090.
23. Kokubo T., Gong D. W., Wootton J. C., Horikoshi M., Roeder R. G., Nakatani Y. Molecular cloning ofDrosophilia. Nature. 367:1994;484-487.
24. Ladurner A. G., Itzhaki L. S., Prat Gay G. d., Fersht A. R. Complementation of peptide fragments of the single domain protein chymotrypsin inhibitor 2. J. Mol. Biol. 273:1997;317-329.
25. Marqusee S., Robbins V. H., Baldwin R. L. Unusually stable helix formation in short alanine-based peptides. Proc. Natl Acad. Sci. USA. 86:1989;5286-5290.
26. Matouschek A., Fersht A. R. Application of physical organic chemistry to engineered mutants of proteins - Hammond postulate behavior in the transition state of protein folding. Proc. Natl Acad. Sci. USA. 90:1993;7814-7818.
27. Matouschek A., Otzen D. E., Itzhaki L. S., Jackson S. E., Fersht A. R. Movement of the position of the transition-state in protein folding. Biochemistry. 34:1995;13656-13662.
28. McPhalen C. A., James M. N. G. Crystal and molecular structure of the serine proteinase inhibitor CI-2 from barley seeds. Biochemistry. 26:1987;261-269.
29. Nagi A. D., Regan L. An inverse correlation between loop length and stability in a four-helix-bundle protein. Folding Design. 2:1997;67-75.
30. Neira J. L., Davis B., Ladurner A. G., Buckle A., Prat Gay G. d., Fersht A. R. Towards the complete characterization of a proteinb folding pathway: the structures of the denatured, transition and native states for the association/folding of two complementary fragments of cleaved chymotrypsin inhibitor 2. Direct evidence for a nucleation-condensation mechanism. Folding Design. 3:1996;189-208.
31. Oneil K. T., Degrado W. F. A thermodynamic scale for the helix-forming tendencies of the commonly occurring amino acids. Science. 250:1990;646-651.
32. Osmark P., Sorensen P., Poulsen F. M. Context dependence of protein secondary structure formation: the 3-dimensional structure and stability of a hybrid between chymotrypsin inhibitor 2 and helix e from subtilisin Carlsberg. Biochemistry. 32:1993;11007-11014.
33. Otzen D. E., Itzhaki L. S., elMasry N. F., Jackson S. E., Fersht A. R. The structure of the transition state for the folding/unfolding of the barley chymotrypsin inhibitor-2 and its implications for mechanisms of protein folding. Proc. Natl Acad. Sci. USA. 91:1994;10422-10425.
34. Pace C. N., Grimsley G. R., Thomson J. A., Barnett B. J. Conformational stability and activity of ribonuclease T1 with zero, one and two intact disulphide bonds. J. Biol. Chem. 263:1988;11820-11825.
35. Perutz M. F. Glutamine repeats and inherited neurodegenerative diseases: molecular aspects. Curr. Opin. Struct. Biol. 6:1996;848-858.
36. Perutz M. F., Staden R., Moens L., Debaere I. Polar zippers. Curr. Biol. 3:1993;249-253.
37. Perutz M. F., Johnson T., Suzuki M., Finch J. T. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc. Natl Acad. Sci. USA. 91:1994;5355-5358.
38. Peterson M. G., Tanese N., Pugh B. F., Tjian R. Functional domains and upstream activation properties of cloned human TATA binding protein. Science. 248:1990;1625-1630.
39. Poland D. C., Scheraga H. A. Statistical mechanics of non-covalent bonds in polyamino acids. VIII. Covalent loops in protein. Biopolymers. 3:1965;379-399.
40. Prat Gay G. d., Fersht A. R. Generation of a family of protein fragments for structure-folding studies. 1. Folding complementation of two fragments of chymotrypsin inhibitor-2 formed by cleavage at its unique methionine residue. Biochemistry. 33:1994;7957-7963.
41. Ruiz-Sanz J., Prat Gay G. d., Otzen D. E., Fersht A. R. Protein fragments as models for events in protein folding pathways: protein engineering analysis of the association of two complementary fragments of the barley chymotrypsin inhibitor-2 (CI-2). Biochemistry. 34:1995;1695-1701.
42. Schellman J. A. The stability of hydrogen-bonded peptide structures in aqueous solution. C. R. Trav. Lab. Carlsberg Ser. Chim. 29:1955;230-259.
43. Shaknovich E., Abkevich V., Ptitsyn O. Conserved residues and the mechanism of protein-folding. Nature. 379:1996;96-98.
44. Shaw G. L., Davis B., Keeler J., Fersht A. R. Backbone dynamics of chymotrypsin inhibitor 2. Effect of braking the active-site bond and its implications for the mechanism of inhibition of serine proteases. Biochemistry. 34:1994;2225-2233.
45. Stott K., Blackburn J. M., Butler P. J. G., Perutz M. F. Incorporation of glutamine repeats makes protein oligomerize: implications for neurodegenerative diseases. Proc. Natl Acad. Sci. USA. 92:1995;6509-6513.
46. Weinzierl R. O., Ruppert S., Dynlacht B. D., Tanese N., Tjian R. Cloning and expression ofDrosophilia. EMBO J. 12:1993;5303-5309.
47. Wootton J. C. Sequences with unusual amino-acid compositions. Curr. Opin. Struct. Biol. 4:1994;413-421.